Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMT 98 Study For Metastatic Disease Rhabdomyosarcoma And Other Malignant Soft Tissue Sarcoma Of Childhood
NCT00025441Phase 2Completed
- Sponsor
- SIOP
- Start
- Nov 1998
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of vincristine, actinomycin D, ifosfamide, carboplatin, epirubicin in rhabdomyosarcoma (RMS), malignant mesenchymal tumor, sponsored by SIOP. Started Nov 1998; status: completed.
02
Drugs
vincristineactinomycin Difosfamidecarboplatinepirubicin
03
Conditions
rhabdomyosarcoma (RMS)malignant mesenchymal tumor
Beyond the preview
Go deeper on NCT00025441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025441.